Impact of metabolic syndrome on the incidence of chronic kidney disease

A Chinese cohort study

Tsan Yang, Chi Hong Chu, Chih Hsung Hsu, Po Chien Hsieh, Tieh Chi Chung, Chyi Huey Bai, San Lin You, Lee Ching Hwang, Chih Ming Lin, Chien An Sun

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Aim: Metabolic syndrome (MetS) is a major culprit in cardiovascular disease and chronic kidney disease (CKD) in Western populations. We studied the longitudinal association between MetS and incident CKD in Chinese adults. Methods: A cohort study was conducted in a nationally representative sample of 4248 Chinese adults in Taiwan. The MetS was defined according to a unified criteria set by several major organizations and CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min per 1.73 m2. Cox proportional hazards regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) adjusted for sex, age, body mass index (BMI) and serum levels of total cholesterol. Results: The prevalence of MetS among participants at baseline recruitment was 15.0% (637/4248). During a median follow-up period of 5.40 years, 208 subjects (4.9%) developed CKD. The multivariate-adjusted HR of CKD in participants with MetS compared with those without was 1.42 (95% CI = 1.03, 1.73). Additionally, there was a significantly graded relationship between the number of the MetS components and risk of CKD. Further, the relation between MetS and incident CKD was more robust in subjects with BMI >27.5 kg/m2 than in those with lower BMI. Conclusion: The results suggest that the presence of MetS was significantly associated with increased risk of incident CKD in a Chinese population. These findings warrant future studies to test the impact of preventing and treating MetS on the reduction of the occurrence of CKD. A longitudinal cohort study investigating the association between the metabolic syndrome and incident CKD in a Chinese population. The presence of the metabolic syndrome was associated with s significant risk of developing CKD (HR 1.42 95% CI 1.03-1.73).

Original languageEnglish
Pages (from-to)532-538
Number of pages7
JournalNephrology
Volume17
Issue number6
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Chronic Renal Insufficiency
Cohort Studies
Incidence
Population
Glomerular Filtration Rate
Taiwan
Longitudinal Studies
Cardiovascular Diseases
Organizations

Keywords

  • Chinese
  • chronic kidney disease
  • cohort study
  • metabolic syndrome
  • obesity

ASJC Scopus subject areas

  • Nephrology

Cite this

Impact of metabolic syndrome on the incidence of chronic kidney disease : A Chinese cohort study. / Yang, Tsan; Chu, Chi Hong; Hsu, Chih Hsung; Hsieh, Po Chien; Chung, Tieh Chi; Bai, Chyi Huey; You, San Lin; Hwang, Lee Ching; Lin, Chih Ming; Sun, Chien An.

In: Nephrology, Vol. 17, No. 6, 08.2012, p. 532-538.

Research output: Contribution to journalArticle

Yang, T, Chu, CH, Hsu, CH, Hsieh, PC, Chung, TC, Bai, CH, You, SL, Hwang, LC, Lin, CM & Sun, CA 2012, 'Impact of metabolic syndrome on the incidence of chronic kidney disease: A Chinese cohort study', Nephrology, vol. 17, no. 6, pp. 532-538. https://doi.org/10.1111/j.1440-1797.2012.01607.x
Yang, Tsan ; Chu, Chi Hong ; Hsu, Chih Hsung ; Hsieh, Po Chien ; Chung, Tieh Chi ; Bai, Chyi Huey ; You, San Lin ; Hwang, Lee Ching ; Lin, Chih Ming ; Sun, Chien An. / Impact of metabolic syndrome on the incidence of chronic kidney disease : A Chinese cohort study. In: Nephrology. 2012 ; Vol. 17, No. 6. pp. 532-538.
@article{0805890e6da340bba2340c273c94da17,
title = "Impact of metabolic syndrome on the incidence of chronic kidney disease: A Chinese cohort study",
abstract = "Aim: Metabolic syndrome (MetS) is a major culprit in cardiovascular disease and chronic kidney disease (CKD) in Western populations. We studied the longitudinal association between MetS and incident CKD in Chinese adults. Methods: A cohort study was conducted in a nationally representative sample of 4248 Chinese adults in Taiwan. The MetS was defined according to a unified criteria set by several major organizations and CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min per 1.73 m2. Cox proportional hazards regression was used to estimate hazard ratios (HR) and 95{\%} confidence intervals (CI) adjusted for sex, age, body mass index (BMI) and serum levels of total cholesterol. Results: The prevalence of MetS among participants at baseline recruitment was 15.0{\%} (637/4248). During a median follow-up period of 5.40 years, 208 subjects (4.9{\%}) developed CKD. The multivariate-adjusted HR of CKD in participants with MetS compared with those without was 1.42 (95{\%} CI = 1.03, 1.73). Additionally, there was a significantly graded relationship between the number of the MetS components and risk of CKD. Further, the relation between MetS and incident CKD was more robust in subjects with BMI >27.5 kg/m2 than in those with lower BMI. Conclusion: The results suggest that the presence of MetS was significantly associated with increased risk of incident CKD in a Chinese population. These findings warrant future studies to test the impact of preventing and treating MetS on the reduction of the occurrence of CKD. A longitudinal cohort study investigating the association between the metabolic syndrome and incident CKD in a Chinese population. The presence of the metabolic syndrome was associated with s significant risk of developing CKD (HR 1.42 95{\%} CI 1.03-1.73).",
keywords = "Chinese, chronic kidney disease, cohort study, metabolic syndrome, obesity",
author = "Tsan Yang and Chu, {Chi Hong} and Hsu, {Chih Hsung} and Hsieh, {Po Chien} and Chung, {Tieh Chi} and Bai, {Chyi Huey} and You, {San Lin} and Hwang, {Lee Ching} and Lin, {Chih Ming} and Sun, {Chien An}",
year = "2012",
month = "8",
doi = "10.1111/j.1440-1797.2012.01607.x",
language = "English",
volume = "17",
pages = "532--538",
journal = "Nephrology",
issn = "1320-5358",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Impact of metabolic syndrome on the incidence of chronic kidney disease

T2 - A Chinese cohort study

AU - Yang, Tsan

AU - Chu, Chi Hong

AU - Hsu, Chih Hsung

AU - Hsieh, Po Chien

AU - Chung, Tieh Chi

AU - Bai, Chyi Huey

AU - You, San Lin

AU - Hwang, Lee Ching

AU - Lin, Chih Ming

AU - Sun, Chien An

PY - 2012/8

Y1 - 2012/8

N2 - Aim: Metabolic syndrome (MetS) is a major culprit in cardiovascular disease and chronic kidney disease (CKD) in Western populations. We studied the longitudinal association between MetS and incident CKD in Chinese adults. Methods: A cohort study was conducted in a nationally representative sample of 4248 Chinese adults in Taiwan. The MetS was defined according to a unified criteria set by several major organizations and CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min per 1.73 m2. Cox proportional hazards regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) adjusted for sex, age, body mass index (BMI) and serum levels of total cholesterol. Results: The prevalence of MetS among participants at baseline recruitment was 15.0% (637/4248). During a median follow-up period of 5.40 years, 208 subjects (4.9%) developed CKD. The multivariate-adjusted HR of CKD in participants with MetS compared with those without was 1.42 (95% CI = 1.03, 1.73). Additionally, there was a significantly graded relationship between the number of the MetS components and risk of CKD. Further, the relation between MetS and incident CKD was more robust in subjects with BMI >27.5 kg/m2 than in those with lower BMI. Conclusion: The results suggest that the presence of MetS was significantly associated with increased risk of incident CKD in a Chinese population. These findings warrant future studies to test the impact of preventing and treating MetS on the reduction of the occurrence of CKD. A longitudinal cohort study investigating the association between the metabolic syndrome and incident CKD in a Chinese population. The presence of the metabolic syndrome was associated with s significant risk of developing CKD (HR 1.42 95% CI 1.03-1.73).

AB - Aim: Metabolic syndrome (MetS) is a major culprit in cardiovascular disease and chronic kidney disease (CKD) in Western populations. We studied the longitudinal association between MetS and incident CKD in Chinese adults. Methods: A cohort study was conducted in a nationally representative sample of 4248 Chinese adults in Taiwan. The MetS was defined according to a unified criteria set by several major organizations and CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min per 1.73 m2. Cox proportional hazards regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) adjusted for sex, age, body mass index (BMI) and serum levels of total cholesterol. Results: The prevalence of MetS among participants at baseline recruitment was 15.0% (637/4248). During a median follow-up period of 5.40 years, 208 subjects (4.9%) developed CKD. The multivariate-adjusted HR of CKD in participants with MetS compared with those without was 1.42 (95% CI = 1.03, 1.73). Additionally, there was a significantly graded relationship between the number of the MetS components and risk of CKD. Further, the relation between MetS and incident CKD was more robust in subjects with BMI >27.5 kg/m2 than in those with lower BMI. Conclusion: The results suggest that the presence of MetS was significantly associated with increased risk of incident CKD in a Chinese population. These findings warrant future studies to test the impact of preventing and treating MetS on the reduction of the occurrence of CKD. A longitudinal cohort study investigating the association between the metabolic syndrome and incident CKD in a Chinese population. The presence of the metabolic syndrome was associated with s significant risk of developing CKD (HR 1.42 95% CI 1.03-1.73).

KW - Chinese

KW - chronic kidney disease

KW - cohort study

KW - metabolic syndrome

KW - obesity

UR - http://www.scopus.com/inward/record.url?scp=84864443641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864443641&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1797.2012.01607.x

DO - 10.1111/j.1440-1797.2012.01607.x

M3 - Article

VL - 17

SP - 532

EP - 538

JO - Nephrology

JF - Nephrology

SN - 1320-5358

IS - 6

ER -